Teledermatology: Skin Care by Photo and Video

Teledermatology is the remote evaluation of skin, hair, and nail conditions using photographs or live video, and it is one of the best-matched pairings of specialty and telemedicine in existence. Dermatology is a visual discipline with a chronic access problem: demand for appointments far exceeds supply in much of the United States, with waits measured in months in underserved regions. Because a large share of dermatologic diagnosis begins with looking, structured photo review lets one dermatologist serve patients far beyond a physical clinic — while a well-defined set of tasks, biopsies above all, keeps in-person care irreplaceable.

How Teledermatology Works in Practice

Teledermatology runs on two distinct models, and the distinction matters more here than in most specialties.

Store-and-Forward Photo Review

In the store-and-forward (asynchronous) model, images and history travel to the dermatologist for review on their own schedule:

1. A patient or referring clinician captures photographs of the skin concern along with a structured history — duration, symptoms, medications, prior treatments.
2. The package is transmitted securely to a dermatologist's queue.
3. The dermatologist reviews the images, renders an assessment, and returns a plan: a diagnosis and treatment, a request for better images, or a referral for in-person evaluation.

Store-and-forward is the workhorse of teledermatology, particularly for e-consults, in which a primary care clinician sends photos and a question to a dermatologist inside the same health system and receives guidance without the patient ever booking a specialty appointment. Health systems and the Veterans Health Administration have used this model at scale for years to compress months-long referral queues into days.

Live Video Visits

Synchronous video visits connect patient and dermatologist in real time. Video shines for interactive history-taking, counseling, and follow-up of chronic conditions — reviewing how psoriasis or eczema has responded to therapy, adjusting medications, checking in on isotretinoin patients. Its weakness is ironic for a visual specialty: real-time video compression discards exactly the fine detail — texture, scale, subtle color variation, border irregularity — that dermatologic diagnosis depends on. For this reason, many video-based programs ask patients to upload photographs beforehand and use the live session for conversation, a hybrid that captures the strengths of both modes. General preparation guidance in telehealth video visit tips applies fully here.

Main Clinical Use Cases

• Rashes and inflammatory conditions. Acne, eczema, psoriasis, contact dermatitis, and similar conditions are teledermatology's core competency — visually diagnosable, common, and largely managed with medications that can be prescribed remotely.
• Lesion triage. For "is this spot concerning?" questions, teledermatology functions as a triage layer: benign-appearing lesions (skin tags, seborrheic keratoses, stable moles) can be reassured or routinely followed, while suspicious lesions are fast-tracked to in-person evaluation and biopsy. Triage does not replace biopsy; it decides who needs one soonest.
• E-consults from primary care. Often the highest-leverage use: many referrals are resolved with photo review and management advice to the primary clinician, reserving scarce dermatology appointments for cases that need them.
• Chronic disease follow-up. Ongoing management of psoriasis, eczema, and patients on systemic medications, where the question is response to therapy rather than new diagnosis.
• Institutional settings. Nursing homes and correctional facilities, where transporting a patient to a dermatology office is costly or logistically difficult, were early adopters of store-and-forward programs.

Access Impact: Dermatology Deserts

The geography of dermatology is starkly uneven. Dermatologists concentrate in metropolitan areas, and large rural regions — including many counties designated by the Health Resources and Services Administration as health professional shortage areas — have no practicing dermatologist at all. In these dermatology deserts, the practical alternative to teledermatology is not an in-person dermatologist visit; it is no dermatologist involvement, with skin disease managed by generalists or not at all.

This is where the access evidence is strongest. Studies of e-consult and store-and-forward programs, including large Veterans Health Administration experience reported in the peer-reviewed literature, consistently show shortened time-to-dermatologist-input and a substantial share of cases resolved without an in-person specialty visit. Teledermatology does not add dermatologists to the workforce — a real constraint — but it redistributes their attention toward the cases that need it, which is the scarce resource in question.

Image Quality Requirements

Image quality is the load-bearing wall of teledermatology; a blurry photo is not a lesser exam but often no exam at all. Programs typically specify:

Modern smartphone cameras exceed the technical requirements for most diagnostic purposes — the limiting factor is technique, not hardware. Some referral programs add dermoscopy, in which a magnifying attachment captures subsurface structures of pigmented lesions; dermoscopic images meaningfully improve remote triage of possible skin cancers in trained hands. Images are protected health information and must move through secure channels, not ordinary text or email — the same obligations described in telehealth security and HIPAA.

Evidence and Limitations

The evidence base, summarized honestly: diagnostic agreement between store-and-forward teledermatology and in-person examination is substantial for common inflammatory conditions and good-quality images, and teledermatology triage reliably identifies most lesions needing urgent evaluation. Professional guidance from the American Academy of Dermatology treats teledermatology as an accepted care model within defined limits. The limits are real:

• No total-body skin exam. A photo review covers what was photographed. In-person full-body exams find melanomas patients did not know they had — on the scalp, back, and other unphotographed sites. Patients at elevated skin-cancer risk still need periodic in-person exams.
• No palpation, no biopsy. Texture, firmness, and depth cannot be photographed, and definitive diagnosis of suspected malignancy requires tissue. Teledermatology's correct output for a suspicious lesion is a fast in-person appointment, never remote reassurance.
• Image dependence. Diagnostic accuracy degrades directly with image quality, and conditions with subtle findings suffer most.
• Skin-tone performance. Dermatologic conditions can present differently across skin tones, photography can exaggerate the difficulty, and both clinical training materials and AI datasets have historically underrepresented darker skin — a documented concern for equity in remote diagnosis.
• Fragmentation risk. Especially in direct-to-consumer models, a remote diagnosis that never reaches the patient's regular chart can fragment care.

DTC Dermatology Apps and Their Trade-Offs

Direct-to-consumer (DTC) teledermatology — apps and websites where a patient submits photos and history, pays a fee, and receives an assessment and often a prescription — is a substantial commercial category, concentrated in acne, hair loss, eczema, and anti-aging skin care. The trade-offs deserve plain statement.

Advantages: genuine convenience and speed for straightforward concerns; transparent cash pricing that can undercut an insurance visit; access without referral or wait; and licensed clinicians, most often reviewing asynchronously.

Trade-offs: the clinician sees only what the patient photographs, with no ability to notice the unrelated suspicious lesion an in-person visit might catch; quality and depth of review vary widely across platforms; records often do not flow to the patient's regular clinicians unless the patient arranges it; and some business models couple evaluation to the sale of prescription products, an incentive structure patients should at least be aware of. Some symptom-checker and lesion-analysis apps also blur the line between wellness information and diagnosis; the FDA regulates software that makes diagnostic claims, and patients should be wary of any app implying it can rule out skin cancer from a photo. Reasonable questions to ask of any platform: who reviews my case and where are they licensed, what happens if my problem is beyond the platform's scope, and can my records be sent to my own clinician.

Reimbursement and Regulatory Notes

At a high level: live video dermatology visits are generally reimbursable as telehealth under the same evolving rules as other specialties, while store-and-forward has historically been the harder billing case — many payers built telehealth policy around real-time interaction, though dedicated codes exist for asynchronous e-consults and remote image evaluation, and several state Medicaid programs explicitly cover store-and-forward. As of early 2026, Medicare telehealth policy remains subject to short-term congressional extensions; readers should verify current coverage with CMS or their payer. DTC platforms largely sidestep insurance with cash pricing. The mechanics are covered in telehealth reimbursement.

On licensing, teledermatology follows telemedicine's general rule: the clinician must be licensed in the state where the patient is located, which is why DTC platforms list available states and why multi-state practices lean on the Interstate Medical Licensure Compact. Several states also impose specific requirements around establishing a patient relationship and prescribing based on store-and-forward review alone. State specifics are mapped in telemedicine laws by state.

What Patients Should Expect

A well-run teledermatology encounter includes clear photo instructions before submission, a structured history questionnaire, review by an identified and licensed clinician, and a written plan — diagnosis, treatment, and explicit guidance on what should prompt escalation. Turnaround for store-and-forward review typically runs from hours to a few business days. Patients should expect, and welcome, referral to in-person care when a lesion is suspicious, when the diagnosis is uncertain, or when a procedure is needed; a teledermatology service that never refers anyone in person is a warning sign, not a convenience. Patients with many moles, fair skin, or a personal or family history of skin cancer should continue periodic in-person full-body exams regardless of how well remote care handles their day-to-day concerns.

Where Teledermatology Is Heading

Two trajectories are worth watching, one organizational and one algorithmic. Organizationally, e-consults embedded in primary care are becoming a default front door to dermatology in integrated systems — a quiet structural change that reroutes a large fraction of referrals. Algorithmically, dermatology is a leading testbed for image-classification AI: research models have matched specialist-level performance on curated lesion datasets in published studies, and tools are emerging for triage support and photo-quality checking. The gap between curated benchmarks and messy real-world photos remains substantial, performance across skin tones is an active and unresolved concern, and in the United States these tools are positioned as assistive aids rather than autonomous diagnosticians — the clinician answering the case remains responsible. The realistic near future is AI that sorts, flags, and quality-controls the image queue while dermatologists render the judgments, mirroring the assistive pattern in teleradiology. For broader context on how specialties divide between remote and in-person work, see telehealth technology.